Clinical Trial Update: Effects of Drospirenone-ethinylestradiol and/or NOMAC-valerate Estradiol on Cardiovascular Risk in Women With Polycystic Ovary Syndrome [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial update evaluating the cardiovascular risk of combined oral contraceptives containing drospirenone/ethinylestradiol and/or nomegestrol a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Polycystic Ovary Syndrome

Drugs mentioned

• drospirenone/ethinylestradiol (drospirenone and ethinylestradiol)
• nomegestrol acetate/estradiol valerate (nomegestrol acetate; estradiol valerate)

Snippet

Sponsor: Catholic University of the Sacred Heart | Conditions: Polycystic Ovary Syndrome | Phase 1 | Status: UNKNOWN